It is clear from the introduction to Biopsy Interpretation of the Breast
by Schnitt and Collins that while advances in molecular biology “will likely have a major impact on the practice of breast pathology in the near future, careful examination of routine histologic sections, supplemented by the judicious use of immunostains, remains at this time the cornerstone for the diagnosis of breast lesions.” This histology-based interactive microscopy course, taught by expert breast pathologists, addresses recurring problems in breast pathology seen in academic, community and private practice, and provides insight in how to resolve them. Target Audience:
Practicing academic and community pathologists, pathologists-in-training and breast pathologists Course Objectives
- Evaluate diagnostic criteria and clinical significance of various common and uncommon benign, in situ and malignant lesions of the breast in both core needle biopsy specimens and surgical specimens
- Describe differential diagnostic problems commonly encountered in breast pathology and develop strategies to resolve them in your practice environment
- Utilize the latest information on the uses and limitations of immunohistochemistry in resolving diagnostic problems in breast pathology
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 12 AMA PRA Category 1 Credits TM
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit.
Physicians can earn a maximum of 12 SAM credit hours.
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty reported no relevant financial relationships: Stuart J. Schnitt, M.D., Benjamin Calhoun, M.D., Ph.D., Laura C. Collins, M.D., Mara Rendi, M.D., Ph.D., and Sandra J. Shin, M.D.
USCAP staff associated with the development of content for this activity reported no relevant financial relationships.